Search research articles
Contact Us
Filters
Showing results (91-100 of 137) with videos related to
Page
of 14
Sort By:
The Journal of Infectious Diseases
|
November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Lancet Regional Health. Americas
|
October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis
Amanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
JAMA Network Open
|
June 25, 2025
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults
Ruth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Lancet (London, England)
|
October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis
Amanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
Influenza and Other Respiratory Viruses
|
March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
Matthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
BMJ (Clinical Research Ed.)
|
October 11, 2022
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Katherine Adams, Jillian P Rhoads, Diya Surie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 26, 2023
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023
Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, et al.
MMWR. Morbidity and Mortality Weekly Report
|
October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022
Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Plos Medicine
|
September 12, 2019
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
Omowunmi Aibana, Chuan-Chin Huang, Said Aboud, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 137) with videos related to
Sort By:
Page
of 14
The Journal of Infectious Diseases
|
November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Lancet Regional Health. Americas
|
October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis
Amanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
JAMA Network Open
|
June 25, 2025
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults
Ruth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Lancet (London, England)
|
October 19, 2024
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis
Amanda B Payne, Janet A Watts, Patrick K Mitchell, et al.
Influenza and Other Respiratory Viruses
|
March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
Matthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
BMJ (Clinical Research Ed.)
|
October 11, 2022
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Katherine Adams, Jillian P Rhoads, Diya Surie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 26, 2023
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023
Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, et al.
MMWR. Morbidity and Mortality Weekly Report
|
October 20, 2022
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022
Amadea Britton, Peter J Embi, Matthew E Levy, et al.
Plos Medicine
|
September 12, 2019
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
Omowunmi Aibana, Chuan-Chin Huang, Said Aboud, et al.
Page
of 14